HK2 and nasopharyngeal carcinoma: This is an important molecular mechanism of cisplatin resistance in nasopharyngeal carcinoma [32], and due to the differences in tumor types, individual differences in patients and even the heterogeneity of cancer cells in the tumor, the mitochondrial localisation changes of HKII under cisplatin stimulation are not clear, and this is also worth studying.